These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6428345)

  • 1. [Severe hypertrophic myocardiopathy in newborn infants. Intra-erythrocyte calcium and the effect of lidoflazine, a calcium-channel inhibitor. Apropos of 2 cases].
    Vliers A; Stijns-Cailteux M; Lintermans J; Trémouroux-Wattiez M; Godfraind T
    Arch Mal Coeur Vaiss; 1984 May; 77(5):496-502. PubMed ID: 6428345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
    Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists and heart failure. Critical review of the literature].
    Devigili G
    Minerva Cardioangiol; 1994 Apr; 42(4):177-89. PubMed ID: 8058185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
    Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
    Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apical hypertrophic myocardiopathy and multiple fistulae between the coronary vessels and the left ventricle].
    Monmeneu JV; Bodí V; Sanchís J; Chorro FJ; Llopis R; Insa L; López Merino V
    Rev Esp Cardiol; 1995 Nov; 48(11):768-70. PubMed ID: 8532948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertropic obstructive cardiomyopathy. A family study].
    Ammann K; Mordasini R; Osterwalder H; Gurtner HP
    Schweiz Med Wochenschr; 1981 Sep; 111(38):1386-94. PubMed ID: 7197051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of calcium entry blockers.
    Flaim SF; Zelis R
    Fed Proc; 1981 Dec; 40(14):2877-81. PubMed ID: 7308498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of hypertrophic obstructive cardiomyopathy with marked T wave changes during the short-term].
    Kageyama F; Iida H; Yositomi A; Ikegaya H; Okano H; Fujimoto K; Tagata M; Nagao M; Yosimi T; Itou T
    Kokyu To Junkan; 1993 Jan; 41(1):69-73. PubMed ID: 8094573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apical hypertrophy as a part of the morphologic spectrum of hypertrophic cardiomyopathy].
    Mori H; Ogawa S; Nakazawa H; Noma S; Fujii I; Nagata M; Akiyama H; Yamazaki H; Handa S; Nakamura Y
    J Cardiogr; 1984 Aug; 14(2):289-300. PubMed ID: 6543445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of cardioplegic myocardial protection with calcium entry blockers.
    Guyton RA; Dorsey LM; Kates RA; Hatcher CR
    J Med Assoc Ga; 1984 Oct; 73(10):707-11. PubMed ID: 6502035
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
    Daenen W; Flameng W
    Angiology; 1981 Aug; 32(8):543-51. PubMed ID: 7258731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting.
    Flameng W; Borgers M; Van der Vusse GJ; Demeyere R; Vandermeersch E; Thoné F; Suy R
    J Thorac Cardiovasc Surg; 1983 May; 85(5):758-68. PubMed ID: 6601746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists in cardiomyopathy.
    Richardson PJ
    Br J Clin Pract Suppl; 1988 Apr; 60():33-7. PubMed ID: 3151269
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypercalcemic cardiomyopathy associated with primary hyperparathyroidism mimicking primary obstructive hypertrophic cardiomyopathy.
    Demers C; Rouleau JL; Leung TK; Tardif JC
    Can J Cardiol; 1998 Nov; 14(11):1397-400. PubMed ID: 9854522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural history of hypertrophic obstructive cardiomyopathy in young patients: apropos of 40 cases].
    Azzano O; Bozio A; Sassolas F; Di Filippo S; Agé C; André M; Jocteur-Monrozier D; Normand J
    Arch Mal Coeur Vaiss; 1995 May; 88(5):667-72. PubMed ID: 7646275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists in the treatment of heart diseases].
    Hess OM; Hirzel HO; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 May; 112(19):689-92. PubMed ID: 7201672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy with outflow tract obstruction-a complication of dexamethasone treatment for subglottic stenosis.
    Balys R; Manoukian J; Zalai C
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):271-3. PubMed ID: 15656964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.